First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Orlando, Giuseppe
Item TypeName
Academic Article Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Academic Article Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans.
Academic Article Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension.
Academic Article Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.
Academic Article Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C.
Academic Article The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
Academic Article Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
Academic Article Operational tolerance after liver transplantation.
Academic Article Clinical operational tolerance after renal transplantation: current status and future challenges.
Academic Article Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation.
Concept Immunosuppressive Agents
Academic Article Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.
Academic Article Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
Academic Article Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
Academic Article Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study.
Academic Article The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy.
Search Criteria
  • Immunosuppressive Agents